Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventing, producing, or reducing harm? Fitness doping risk and enabling environments
April Henning, Jesper Andreasson
Drugs Education Prevention and Policy (2020) Vol. 29, Iss. 1, pp. 95-104
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback
Timothy Piatkowski, Ross Coomber, Cameron Francis, et al.
Addiction (2025)
Open Access | Times Cited: 4
Anything but androgens: How image and performance enhancing drug consumers manage body composition and health through off-label use of medicines
Timothy Piatkowski, Kim Akrigg, Luke Cox, et al.
Performance Enhancement & Health (2025), pp. 100329-100329
Open Access | Times Cited: 2
Beyond the law: Exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 32
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 17
‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 14
“I go back to it every f**king time”: the normalization of problematic Trenbolone use in online anabolic-androgenic steroid communities
Harry Lamb, Matthew Dunn, Ingrid Amalia Havnes, et al.
Addiction Research & Theory (2024), pp. 1-7
Open Access | Times Cited: 10
What is the prevalence of anabolic‐androgenic steroid use among women? A systematic review
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Addiction (2024) Vol. 119, Iss. 12, pp. 2088-2100
Open Access | Times Cited: 9
The material practices and social dimensions of community care among people who use, produce, and supply image and performance enhancing drugs
Timothy Piatkowski, Luke Cox, Katinka van de Ven, et al.
Addiction Research & Theory (2025), pp. 1-8
Open Access | Times Cited: 1
If you find me on the floor, stick some sugar in my mouth : The social production (and protection) of insulin risk among IPED communities
Kim Akrigg, Luke Cox, Luke A. Turnock, et al.
Drugs Education Prevention and Policy (2025), pp. 1-12
Open Access | Times Cited: 1
The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 19
Social media influencers, YouTube & performance and image enhancing drugs: A narrative-typology
Luke Cox, Letizia Paoli
Performance Enhancement & Health (2023) Vol. 11, Iss. 4, pp. 100266-100266
Open Access | Times Cited: 17
The ethics of enhancement among image and performance enhancing drug coaches
Timothy Piatkowski, Luke Cox, Rick Collins
Health Sociology Review (2024), pp. 1-15
Open Access | Times Cited: 5
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 12
Consuming ‘God Juice’: Using ‘ethnopharmacological‐connoisseurship’ to situate trenbolone use and knowledge among image and performance enhancing drug communities
Timothy Piatkowski, Nick Gibbs, David L. Neumann, et al.
Drug and Alcohol Review (2024)
Open Access | Times Cited: 4
Perspectives, motivations and behaviors of amateur bodybuilders regarding doping and anti-doping: A systematic review
René Paasch, Gunnar Mau, Oliver Korol
Performance Enhancement & Health (2025) Vol. 13, Iss. 3, pp. 100336-100336
Closed Access
From ‘bro, do you even lift?’ to ‘bro, do you even science?’: How the relationship between science and broscience can inform the development of allied image and performance enhancing drug harm reduction
Mair Underwood
Performance Enhancement & Health (2024), pp. 100291-100291
Open Access | Times Cited: 3
The Enhanced Games: Prohibition, harm reduction & the future of sport
Luke A. Turnock
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100295-100295
Open Access | Times Cited: 3
Dealing with doping. A plea for better science, governance and education
Jules A. A. C. Heuberger, April Henning, Adam F. Cohen, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 2, pp. 566-578
Open Access | Times Cited: 19
Stigma and the Use of Anabolic Androgenic Steroids by Men in the United Kingdom
Jim McVeigh, Geoff Bates
Springer eBooks (2022), pp. 121-146
Closed Access | Times Cited: 14
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare
Geoff Bates, Scott T.C. Shepherd, Jim McVeigh
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 630-635
Open Access | Times Cited: 17
Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and Anabolic-Androgenic Steroid using patients in the UK
Neha Prasad Ainsworth, Sam N. Thrower, Andrea Petróczi
Emerging Trends in Drugs Addictions and Health (2022) Vol. 2, pp. 100033-100033
Open Access | Times Cited: 9
Profile of gym-goers who do not use performance-enhancement substances
Ana Sofia Tavares, Elisabete Carolino, Pedro Teques, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access
A netnographic study of anabolic‐androgenic steroid initiation videos on YouTube
Matthew Gill, Timothy Piatkowski, Matthew Dunn
Drug and Alcohol Review (2024)
Open Access
Page 1 - Next Page

Scroll to top